Literature DB >> 9867222

Mutations in the hepatocyte nuclear factor-1alpha gene in Caucasian families originally classified as having Type I diabetes.

A M Møller1, L T Dalgaard, F Pociot, J Nerup, T Hansen, O Pedersen.   

Abstract

Mutations in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene are the cause of maturity-onset diabetes of the young type 3 (MODY3), which is characterised by a severe impairment of insulin secretion and an early onset of the disease. Also at onset of diabetes some MODY patients show similar clinical symptoms and signs as patients with Type I (insulin-dependent) diabetes mellitus. The objective of this study was to estimate the prevalence of MODY3 patients misclassified as Type I diabetic patients. From a large population-based sample of unrelated Danish Caucasian Type I diabetic patients with an affected first degree relative, 39 patients (6.7%) who did not carry any high-risk HLA-haplotypes, i.e. DR3 or DR4 or both were examined by single-strand conformational polymorphism scanning and direct sequencing of the coding region and the minimal promoter of the HNF-1alpha gene. Four of the 39 Type I diabetic patients (10%) were identified as carrying mutations in the HNF-1alpha gene. One patient carried a missense mutation (Glu48Lys) in exon 1, two patients carried a missense mutation (Cys241Gly) in exon 4 and one patient carried a frameshift mutation (Pro291fsdelA) in exon 4. The mutations were all identified in heterozygous form, segregated with diabetes, and were not identified in 84 unrelated, healthy subjects. Furthermore, family history in three of the four families showed diabetes in four consecutive generations, suggestive of an autosomal dominant inheritance. In conclusion, about 10% of Danish diabetic patients without a high-risk HLA-haplotype, originally classified as having Type I diabetes could have diabetes caused by mutations in the HNF-1alpha gene. Clinical awareness of family history of diabetes and mode of inheritance might help to identify and reclassify these diabetic subjects as MODY3 patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9867222     DOI: 10.1007/s001250051101

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

1.  Genetic Counseling for Diabetes Mellitus.

Authors:  Stephanie A Stein; Kristin L Maloney; Toni I Pollin
Journal:  Curr Genet Med Rep       Date:  2014-06-01

2.  Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction.

Authors:  H Wang; P A Antinozzi; K A Hagenfeldt; P Maechler; C B Wollheim
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

Review 3.  Newly defined genetic diabetes syndromes: maturity onset diabetes of the young.

Authors:  William E Winter
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

4.  Identifying monogenic diabetes in a pediatric cohort with presumed type 1 diabetes.

Authors:  Rachelle G Gandica; Wendy K Chung; Liyong Deng; Robin Goland; Mary Pat Gallagher
Journal:  Pediatr Diabetes       Date:  2014-08-01       Impact factor: 4.866

5.  Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach.

Authors:  G Alkorta-Aranburu; D Carmody; Y W Cheng; V Nelakuditi; L Ma; Jazzmyne T Dickens; S Das; S A W Greeley; D Del Gaudio
Journal:  Mol Genet Metab       Date:  2014-09-28       Impact factor: 4.797

6.  Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes.

Authors:  Jaime L Peters; Rob Anderson; Chris Hyde
Journal:  BMJ Open       Date:  2013-05-28       Impact factor: 2.692

7.  Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.

Authors:  Rachel E J Besser; Maggie H Shepherd; Timothy J McDonald; Beverley M Shields; Bridget A Knight; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

Review 8.  MODY: history, genetics, pathophysiology, and clinical decision making.

Authors:  Stefan S Fajans; Graeme I Bell
Journal:  Diabetes Care       Date:  2011-08       Impact factor: 19.112

Review 9.  Monogenic diabetes in children and young adults: Challenges for researcher, clinician and patient.

Authors:  Annabelle S Slingerland
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

10.  Evaluation of a target region capture sequencing platform using monogenic diabetes as a study-model.

Authors:  Rui Gao; Yanxia Liu; Anette Prior Gjesing; Mette Hollensted; Xianzi Wan; Shuwen He; Oluf Pedersen; Xin Yi; Jun Wang; Torben Hansen
Journal:  BMC Genet       Date:  2014-01-29       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.